Avanos Medical AVNS Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value at other companies
Other financials
Where this comes from
Reported directly by Avanos Medical in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue.
The official record: Avanos Medical’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about Avanos Medical's share based compensation arrangement by share based payment award options exercises in period total intrinsic value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Avanos Medical's share based compensation arrangement by share based payment award options exercises in period total intrinsic value?
- Avanos Medical (AVNS) reported share based compensation arrangement by share based payment award options exercises in period total intrinsic value of $0 in Q4 2025.
- What is the long-term trend for Avanos Medical's share based compensation arrangement by share based payment award options exercises in period total intrinsic value?
- Over 4 years (2021 to 2025), Avanos Medical's share based compensation arrangement by share based payment award options exercises in period total intrinsic value has grown at a -100.0% compound annual growth rate (CAGR), from $1.6M to $0.
- What does share based compensation arrangement by share based payment award options exercises in period total intrinsic value mean?
- The total intrinsic value realized by employees upon the exercise of stock options during the reporting period. This represents the difference between the market price of the stock at the time of exercise and the exercise price, reflecting the actual economic benefit captured by employees.